Roactemra News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roactemra. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roactemra Today - Breaking & Trending Today

FDA Approves TOFIDENCE™ (tocilizumab-bavi) a Biosimilar of ACTEMRA® developed by Bio-Thera Solutions

Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets, announced that its partner Biogen recently received notification from the United States Food and Drug Administration (FDA) on the approval of TOFIDENCE (tocilizumab-bavi) intravenous formulation, a biosimilar monoclonal antibody referencing ACTEMRA. The TOFIDENCE intravenous formulation is approved for the treatment of moderately to severely active rheuma ....

Hong Kong , United States , Wechat Bio Thera , Shengfeng Li , Biogen Inc , Bio Thera Solutions , Bio Thera Solutions Ltd , Disease Modifying Anti Rheumatic Drugs , Juvenile Idiopathic Arthritis , Important Safety Information , Thera Solutions , Rheumatoid Arthritis , Juvenile Idiopathic Arthritis , Pharmaceutical Company , Monoclonal Antibody , Dbio Thera , Nited States Food And Drug Administration ,

Roche Holding plans to sell 800-employee drug manufacturing plant in Vacaville

The company said it is seeking a buyer that will continue to use the plant as an operating facility. ....

Theresa Graham , Thomas Schinecker , Regeneron Pharmaceuticals , Roche News , Roche Holding ,

China Anti-Rheumatic Drug Market Forecasts Report 2022-2027

Dublin, Jan. 20, 2023 (GLOBE NEWSWIRE) The "China Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027" report has been added to . ....

Roche Actemra , Fistulising Crohn , Eli Lilly , Roche Ltd , Research Methodology , Company Profiles , Mabwell Bioscience Co , China National Health Commission , Pfizer Inc , Chinese National Medical Products Administration , Shanghai Junshi Biosciences Co , Abbvie Inc , Research Data , Osteoarthritis Research Society International , Porter Five Forces Analysis , Anti Rheumatic Drug Market , Antirheumatic Drugs Market , National Health Commission , Antirheumatic Drugs , Shanghai Junshi Biosciences , Mabwell Bioscience , Five Year Plan , Major New Drug Creation Science , Adult Ulcerative Colitis , Topics Covered , Five Forces ,

Health News Roundup: First foreign COVID vaccines head to China from Germany; U.S. FDA approves Roche's COVID-19 antibody and more

It is the first FDA-approved monoclonal antibody to treat COVID-19, Roche said. WHO says China may be struggling to keep a tally of COVID cases China may be struggling to keep a tally of COVID-19 infections as the country experiences a big spike in cases, a senior World Health Organization official said on Wednesday, amid concerns about a lack of data from the country. ....

United States , Xu Yafa , Gerald Muwonge , World Health Organization , Drug Administration , Roche Holding , Africa Germany 39 S , The United States , European Union 39 S , Hsv 2 , S Fda , Ero Covid Quot , Roche Holding Ag ,

FDA Okays Roche's Actemra For Treatment Of COVID-19 In Hospitalized Adults

SOUTH SAN FRANCISCO (dpa-AFX) - The U.S. Food and Drug Administration has approved Roche's (RHHBY) Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients ....

United States , Drug Administration , More Such Health News , Use Authorization ,